PMID- 26658035
OWN - NLM
STAT- MEDLINE
DCOM- 20160919
LR  - 20151215
IS  - 1536-4828 (Electronic)
IS  - 0885-3177 (Linking)
VI  - 45
IP  - 1
DP  - 2016 Jan
TI  - Challenges and Updates in the Management of Exocrine Pancreatic Insufficiency.
PG  - 1-4
LID - 10.1097/MPA.0000000000000457 [doi]
FAU - Hart, Phil A
AU  - Hart PA
AD  - From the Section of Pancreatic Disorders, Division of Gastroenterology,
      Hepatology, and Nutrition, The Ohio State University Wexner Medical Center,
      Columbus, OH.
FAU - Conwell, Darwin L
AU  - Conwell DL
LA  - eng
PT  - Editorial
PT  - Review
PL  - United States
TA  - Pancreas
JT  - Pancreas
JID - 8608542
RN  - 0 (Dietary Fats)
RN  - EC 3.1.1.3 (Lipase)
RN  - EC 3.1.1.3 (PNLIP protein, human)
SB  - IM
MH  - Diet, Fat-Restricted
MH  - Dietary Fats/*metabolism
MH  - *Enzyme Replacement Therapy/adverse effects
MH  - Exocrine Pancreatic Insufficiency/diagnosis/*drug therapy/enzymology/etiology
MH  - Humans
MH  - Lipase/adverse effects/metabolism/*therapeutic use
MH  - Pancreas, Exocrine/*enzymology
MH  - Predictive Value of Tests
MH  - Risk Factors
MH  - Treatment Outcome
EDAT- 2015/12/15 06:00
MHDA- 2016/09/20 06:00
CRDT- 2015/12/15 06:00
PHST- 2015/12/15 06:00 [entrez]
PHST- 2015/12/15 06:00 [pubmed]
PHST- 2016/09/20 06:00 [medline]
AID - 10.1097/MPA.0000000000000457 [doi]
AID - 00006676-201601000-00001 [pii]
PST - ppublish
SO  - Pancreas. 2016 Jan;45(1):1-4. doi: 10.1097/MPA.0000000000000457.